Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31295041

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2019 Oct 20
First author
Hillmen P

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Oct 20;37(30):2711-2713. doi: 10.1200/JCO.19.01718.
    note
    Source null
    related pmid
    31461378
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2020 May 10;38(14):1644. doi: 10.1200/JCO.20.00411.
    note
    Source null
    related pmid
    32375017
    relationship
    Erratum in

Authors and identifiers

  1. name
    Hillmen P
    type
    Author
  2. name
    Rawstron AC
    type
    Author
  3. name
    Brock K
    type
    Author
  4. name
    Muñoz-Vicente S
    type
    Author
  5. name
    Yates FJ
    type
    Author
  6. name
    Bishop R
    type
    Author
  7. name
    Boucher R
    type
    Author
  8. name
    MacDonald D
    type
    Author
  9. name
    Fegan C
    type
    Author
  10. name
    McCaig A
    type
    Author
  11. name
    Schuh A
    type
    Author
  12. name
    Pettitt A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hillmen P
    type
    Author
  2. name
    Rawstron AC
    type
    Author
  3. name
    Brock K
    type
    Author
  4. name
    Muñoz-Vicente S
    type
    Author
  5. name
    Yates FJ
    type
    Author
  6. name
    Bishop R
    type
    Author
  7. name
    Boucher R
    type
    Author
  8. name
    MacDonald D
    type
    Author
  9. name
    Fegan C
    type
    Author
  10. name
    McCaig A
    type
    Author
  11. name
    Schuh A
    type
    Author
  12. name
    Pettitt A
    type
    Author
bibliography ids
  1. nci-bib-1ee534e3f24e204c358c5816
book metadata
content sha256
3213393507bfe68e872499e8750155d54e7f65feb187deadb55786bebaa9eae7
document type
citation
dois
  1. 10.1200/JCO.19.00894
electronic publication date
display
2019 Jul 11
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31295041
immutable id
pubmed:31295041@3213393507bfe68e872499e8750155d54e7f65feb187deadb55786bebaa9eae7
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
30
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2722-2729
volume
37
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Oct 20;37(30):2711-2713. doi: 10.1200/JCO.19.01718.
    note
    Source null
    related pmid
    31461378
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2020 May 10;38(14):1644. doi: 10.1200/JCO.20.00411.
    note
    Source null
    related pmid
    32375017
    relationship
    Erratum in
outcomes validated
false
pmid
31295041
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
6746da6171b6be043d8b45af0884d6e17f0ce4cf4cecc9c10f7b7db70a4f9a62
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Oct 20
precision
day
year
2019
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31295041/
title
Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study.

Preserved source evidence · Not medical advice